Local view for "http://purl.org/linkedpolitics/eu/plenary/2009-11-11-Speech-3-209"

Predicate	Value (sorted: default)
rdf:type	lpv_eu:Speech2
dcterms:Date	"2009-11-11"^^xsd:date2
dcterms:Is Part Of	lp_eu:One-minute speeches on matters of political importance2
dcterms:Language	"fr"^^xsd:language2
lpv:document identification number	"en.20091111.19.3-209"2
lpv:hasSubsequent	lp_eu:2009-11-11-Speech-3-2102
lpv:speaker	lp:Michèle Rivasi2
lpv:spokenAs	unknown; Europe Écologie (2009-07-14--2014-06-30)3 vice-chair; Delegation to the ACP-EU Joint Parliamentary Assembly (2009-09-17--2014-06-30)3 member; ITRE (2009-07-16--2012-01-18)3 member; Delegation to the Euronest Parliamentary Assembly (2009-09-16--2014-06-30)3 substitute; Delegation for relations with Belarus (2009-09-16--2013-09-18)3 member; G/EFA (2009-07-14--2011-12-12)3 substitute; ENVI (2009-07-16--2012-01-18)3
lpv:translated text	"Madam President, I, for my part, would like to put some questions to you regarding the problem of the AH1N1 flu vaccine. Currently, the MEPs and their assistants are being asked to have the inoculation, and I would like to share a number of concerns with you. Firstly, what is the relationship between the risks and benefits? At the moment, the benefits are few, since this is not a flu that causes a huge number of deaths – nowhere near as many as seasonal flu, in any case. With regard to the risks, on the other hand, we have enough time to consider this aspect, and I would like, in particular, to address the problem of adjuvants. I would like to point something out to you that is rather odd: in the United States, the use of squalene in adjuvants has been prohibited, but the European Medicines Agency has authorised it since most vaccines contain squalene. The second point is that the European Medicines Agency has confirmed to us that a clinical trial was not performed on children and pregnant women and that it did not have access to an extrapolation from the prototype. I therefore think that more harmonisation may be required."@en1
lpv:videoURI	<go to Events_and_structure europarl>2

Named graphs describing this resource:

The resource appears as object in 2 triples

Context graph